According to the latest American College of Medical Genetics and Genomics (ACMG) guidelines [19] and the ClinGen Hearing Loss Specification, we consider this variant to be pathogenic (PVS1 + PM1 + PM2 + PP1_strong + PP4). This evidence concerns the gene TMEM11 and hearing loss disorder.